Analysts’ Viewpoint on Continence Care Market Scenario
Telehealth services are anticipated to rapidly grow in the healthcare industry, owing to the onset of the coronavirus pandemic. Companies need to address incidence of catheter-associated urinary tract infections (CAUTIs). Thus, to overcome this issue, companies in the continence care market should shift from offering traditional indwelling catheters and rather increase availability of urinary catheters such as intermittent catheters. Manufacturers are innovating in non-implantable and wearable electrical stimulation devices due to their efficiency in treating & managing stress, urge, and mixed incontinence amongst men & women. Companies should diversify production in OTC products such as tampons and drugs such as skeletal muscle relaxants to expand revenue streams.
The rise in demand for minimally invasive surgery and devices to minimize complications is growing prominent in the continence care market. These devices help to prevent bladder injury and increase rates of improved product outcomes, which help to reduce hospitalization and treatment costs. For instance, the non-implantable electrical stimulation devices for pelvic floor are comparatively cheaper than implantable devices.
Companies in the continence care market are boosting R&D capabilities to increase the availability of over-the-counter (OTC) products that are FDA approved and ideal for home care. Patented home continence care devices are boosting the credibility of med-tech companies. There is a demand for devices that help to treat stress, urge, mixed urinary incontinence, and bowel incontinence.
Services for continence care in healthcare facilities have been altered due to the coronavirus pandemic. Telephone consultations are gaining prominence in the continence care market. However, in some cases services have either stopped and have reduced in number due to the pandemic. Nevertheless, healthcare companies are increasing efforts to maintain robust supply of products to prevent interruptions in providing continence care in healthcare facilities and in home setting.
Companies in the continence care market are working at breakneck speeds to maintain continued production activities and meet demands of children, elderly, and people with learning disabilities. Suppliers and manufacturers are taking efforts to overcome bottlenecks in transport & distribution to ensure continuous supply of products & continence care devices.
The availability of alternative treatment and management methods such as incontinence pads and therapeutic drugs such as muscarinic receptor antagonists are affecting sales of continence care devices. Thus, apart from devices including urinary catheters and urine drainage bags, manufacturers should diversify their production in alternative treatment and management products such as absorbable underwear and anticholinergic/antispasmodic agents to expand their revenue streams.
Companies in the continence care market should extend their production in OTC products such as tampons that are useful for temporary management of urinary incontinence among all age groups.
North America, followed by Europe and Asia Pacific, is expected to dictate the highest revenue share in the continence care market during the forecast period. This is evident, owing to favorable medical reimbursement policies for continence care products in developed countries such as the U.S., the U.K. and Australia, among others. Healthcare companies are investing in improving the infrastructure of developing economies in Asia Pacific owing to gradually increasing disposable income of people.
Recently electrical stimulation devices have been considered as the necessary treatment devices by the Centers for Medicare and Medicare Services (CMS) in the U.S. Such trends are increasing the consumption of these devices and generating new avenues for market players. Reimbursement for the application of electrical stimulation (manual) for pelvic floor for 15 minutes procedure is covered under the CPT code of 97032 by the U.S. reimbursement programs.
Only a small number of companies are currently operating in the non-implantable and wearable electrical stimulation devices market landscape. Thus, startups and emerging market players should capitalize on this opportunity to boost research in developing non-implantable and wearable electrical stimulation devices.
Non-implantable and wearable electrical stimulation devices offer several advantages over implantable ones. Hence, manufacturers in the continence care market are increasing output capacities in these devices. Cost efficiency of non-implantable and wearable electrical stimulation devices is benefitting both patients and med-tech companies.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 14 Bn |
|
Market Forecast Value in 2031 |
US$ 26 Bn |
|
Growth Rate (CAGR) |
5.7% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross-segment and regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Continence care market was valued at US$ 14 Bn in 2020 and is expected to reach the value of US$ 26 Bn by the end of 2031
Continence care market is estimated to expand at a CAGR of 5.7% from 2021 to 2031
Continence care market is driven by rise in prevalence of stress incontinence and urge urinary incontinence, increase in the geriatric population, and technological advancements
The absorbents segment is anticipated to dominate the global continence care market, accounting for 71.3% share
Key players operating in the continence care market are ABENA A/S, Atlantic Therapeutics, Attends Healthcare Products, Inc., B. Braun Melsungen AG, Beambridge Medical Ltd., Becton
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Continence Care Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continence Care Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Reimbursement Scenario, by Region/globally
5.4. Key Industrial Events (licensing partnership/merger & acquisition)
5.5. COVID-19 Impact Analysis
5.6. Porter’s Five Force Analysis
6. Global Continence Care Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Urinary Catheters
6.3.1.1. External Catheters
6.3.1.2. Indwelling Catheters
6.3.1.3. Intermittent Catheters
6.3.1.4. Catheter Accessories
6.3.2. Male Bodyworn Urinals
6.3.3. Mechanical Devices for Women with Urinary Incontinence
6.3.3.1. Urethral Inserts
6.3.3.2. Intravaginal Devices
6.3.4. Urine Drainage Bags & Accessories
6.3.4.1. Leg Drainage Bags
6.3.4.2. Night Drainage Bags
6.3.4.3. Accessories
6.3.5. Absorbents
6.3.6. Penile Clamps
6.3.7. Non-implantable Electrical Stimulation Devices
6.3.8. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Continence Care Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Urge Urinary Incontinence (UUI)
7.3.2. Stress Urinary Incontinence (SUI)
7.3.3. Mixed Urinary Incontinence (MUI)
7.3.4. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Continence Care Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Acute Care Facilities
8.3.2. Long Term Care Facilities
8.3.3. Homecare
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Continence Care Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Continence Care Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Urinary Catheters
10.2.1.1. External Catheters
10.2.1.2. Indwelling Catheters
10.2.1.3. Intermittent Catheters
10.2.1.4. Catheter Accessories
10.2.2. Male Bodyworn Urinals
10.2.3. Mechanical Devices for Women with Urinary Incontinence
10.2.3.1. Urethral Inserts
10.2.3.2. Intravaginal Devices
10.2.4. Urine Drainage Bags & Accessories
10.2.4.1. Leg Drainage Bags
10.2.4.2. Night Drainage Bags
10.2.4.3. Accessories
10.2.5. Absorbents
10.2.6. Penile Clamps
10.2.7. Non-implantable Electrical Stimulation Devices
10.2.8. Others
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Urge Urinary Incontinence (UUI)
10.3.2. Stress Urinary Incontinence (SUI)
10.3.3. Mixed Urinary Incontinence (MUI)
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Acute Care Facilities
10.4.2. Long Term Care Facilities
10.4.3. Homecare
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Continence Care Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Urinary Catheters
11.2.1.1. External Catheters
11.2.1.2. Indwelling Catheters
11.2.1.3. Intermittent Catheters
11.2.1.4. Catheter Accessories
11.2.2. Male Bodyworn Urinals
11.2.3. Mechanical Devices for Women with Urinary Incontinence
11.2.3.1. Urethral Inserts
11.2.3.2. Intravaginal Devices
11.2.4. Urine Drainage Bags & Accessories
11.2.4.1. Leg Drainage Bags
11.2.4.2. Night Drainage Bags
11.2.4.3. Accessories
11.2.5. Absorbents
11.2.6. Penile Clamps
11.2.7. Non-implantable Electrical Stimulation Devices
11.2.8. Others
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Urge Urinary Incontinence (UUI)
11.3.2. Stress Urinary Incontinence (SUI)
11.3.3. Mixed Urinary Incontinence (MUI)
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Acute Care Facilities
11.4.2. Long Term Care Facilities
11.4.3. Homecare
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Continence Care Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Urinary Catheters
12.2.1.1. External Catheters
12.2.1.2. Indwelling Catheters
12.2.1.3. Intermittent Catheters
12.2.1.4. Catheter Accessories
12.2.2. Male Bodyworn Urinals
12.2.3. Mechanical Devices for Women with Urinary Incontinence
12.2.3.1. Urethral Inserts
12.2.3.2. Intravaginal Devices
12.2.4. Urine Drainage Bags & Accessories
12.2.4.1. Leg Drainage Bags
12.2.4.2. Night Drainage Bags
12.2.4.3. Accessories
12.2.5. Absorbents
12.2.6. Penile Clamps
12.2.7. Non-implantable Electrical Stimulation Devices
12.2.8. Others
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Urge Urinary Incontinence (UUI)
12.3.2. Stress Urinary Incontinence (SUI)
12.3.3. Mixed Urinary Incontinence (MUI)
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Acute Care Facilities
12.4.2. Long Term Care Facilities
12.4.3. Homecare
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Continence Care Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Urinary Catheters
13.2.1.1. External Catheters
13.2.1.2. Indwelling Catheters
13.2.1.3. Intermittent Catheters
13.2.1.4. Catheter Accessories
13.2.2. Male Bodyworn Urinals
13.2.3. Mechanical Devices for Women with Urinary Incontinence
13.2.3.1. Urethral Inserts
13.2.3.2. Intravaginal Devices
13.2.4. Urine Drainage Bags & Accessories
13.2.4.1. Leg Drainage Bags
13.2.4.2. Night Drainage Bags
13.2.4.3. Accessories
13.2.5. Absorbents
13.2.6. Penile Clamps
13.2.7. Non-implantable Electrical Stimulation Devices
13.2.8. Others
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Urge Urinary Incontinence (UUI)
13.3.2. Stress Urinary Incontinence (SUI)
13.3.3. Mixed Urinary Incontinence (MUI)
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Acute Care Facilities
13.4.2. Long Term Care Facilities
13.4.3. Homecare
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Continence Care Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Urinary Catheters
14.2.1.1. External Catheters
14.2.1.2. Indwelling Catheters
14.2.1.3. Intermittent Catheters
14.2.1.4. Catheter Accessories
14.2.2. Male Bodyworn Urinals
14.2.3. Mechanical Devices for Women with Urinary Incontinence
14.2.3.1. Urethral Inserts
14.2.3.2. Intravaginal Devices
14.2.4. Urine Drainage Bags & Accessories
14.2.4.1. Leg Drainage Bags
14.2.4.2. Night Drainage Bags
14.2.4.3. Accessories
14.2.5. Absorbents
14.2.6. Penile Clamps
14.2.7. Non-implantable Electrical Stimulation Devices
14.2.8. Others
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Urge Urinary Incontinence (UUI)
14.3.2. Stress Urinary Incontinence (SUI)
14.3.3. Mixed Urinary Incontinence (MUI)
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Acute Care Facilities
14.4.2. Long Term Care Facilities
14.4.3. Homecare
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competitive Landscape
15.1. Market Share Analysis of Key Companies, by Region (2020)
15.2. Company Profiles
15.2.1. Abena A/S
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Atlantic Therapeutics
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Attends Healthcare Products, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. B. Braun Melsungen AG
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Beambridge Medical Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Becton, Dickinson and Company
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Boston Scientific Corporation
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Coloplast A/S
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. ConvaTec Group PLC
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Drylock Technologies
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. Hollister Incorporated
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. InControl Medical LLC
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Strategic Overview
15.2.12.4. SWOT Analysis
15.2.13. Kimberly-Clark Corporation
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. Financial Overview
15.2.13.4. Strategic Overview
15.2.13.5. SWOT Analysis
15.2.14. Optimum Medical Limited
15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.14.2. Product Portfolio
15.2.14.3. Strategic Overview
15.2.14.4. SWOT Analysis
15.2.15. Pacey MedTech Ltd.
15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.15.2. Product Portfolio
15.2.15.3. Strategic Overview
15.2.15.4. SWOT Analysis
15.2.16. Renew Medical, Inc.
15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.16.2. Product Portfolio
15.2.16.3. Strategic Overview
15.2.16.4. SWOT Analysis
15.2.17. Uresta
15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.17.2. Product Portfolio
15.2.17.3. Strategic Overview
15.2.17.4. SWOT Analysis
15.2.18. Urocare Products, Inc.
15.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.18.2. Product Portfolio
15.2.18.3. Strategic Overview
15.2.18.4. SWOT Analysis
15.2.19. Vesiflo, Inc.
15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.19.2. Product Portfolio
15.2.19.3. Strategic Overview
15.2.19.4. SWOT Analysis
List of Tables
Table 01: Global Continence Care Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
Table 02: Global Continence Care Market Value (US$ Mn) Forecast, by Urinary Catheters, 2017‒2031
Table 03: Global Continence Care Market Value (US$ Mn) Forecast, by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Table 04: Global Continence Care Market Value (US$ Mn) Forecast, by Urine Drainage Bags & Accessories, 2017‒2031
Table 05: Global Continence Care Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 06: Global Continence Care Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Global Continence Care Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America Continence Care Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: North America Continence Care Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
Table 10: North America Continence Care Market Value (US$ Mn) Forecast, by Urinary Catheters, 2017‒2031
Table 11: North America Continence Care Market Value (US$ Mn) Forecast, by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Table 12: North America Continence Care Market Value (US$ Mn) Forecast, by Urine Drainage Bags & Accessories, 2017‒2031
Table 13: North America Continence Care Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 14: North America Continence Care Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Europe Continence Care Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 16: Europe Continence Care Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
Table 17: Europe Continence Care Market Value (US$ Mn) Forecast, by Urinary Catheters, 2017‒2031
Table 18: Europe Continence Care Market Value (US$ Mn) Forecast, by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Table 19: Europe Continence Care Market Value (US$ Mn) Forecast, by Urine Drainage Bags & Accessories, 2017‒2031
Table 20: Europe Continence Care Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 21: Europe Continence Care Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 22: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 23: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
Table 24: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by Urinary Catheters, 2017‒2031
Table 25: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Table 26: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by Urine Drainage Bags & Accessories, 2017‒2031
Table 27: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 28: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 29: Latin America Continence Care Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 30: Latin America Continence Care Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
Table 31: Latin America Continence Care Market Value (US$ Mn) Forecast, by Urinary Catheters, 2017‒2031
Table 32: Latin America Continence Care Market Value (US$ Mn) Forecast, by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Table 33: Latin America Continence Care Market Value (US$ Mn) Forecast, by Urine Drainage Bags & Accessories, 2017‒2031
Table 34: Latin America Continence Care Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 35: Latin America Continence Care Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 36: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 37: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
Table 38: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by Urinary Catheters, 2017‒2031
Table 39: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Table 40: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by Urine Drainage Bags & Accessories, 2017‒2031
Table 41: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 42: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Continence Care Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Continence Care Market Value Share, by Product Type, 2020
Figure 03: Continence Care Market Value Share, by Indication, 2020
Figure 04: Continence Care Market Value Share, by End-user, 2020
Figure 05: Global Continence Care Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 06: Global Continence Care Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 07: Global Continence Care Market Value (US$ Mn), by Urinary Catheters, 2017‒2031
Figure 08: Global Continence Care Market Value (US$ Mn), by Male Bodyworn Urinals, 2017‒2031
Figure 09: Global Continence Care Market Value (US$ Mn), by Mechanical Devices for Women with Urinary Incontinence, 2017‒2031
Figure 10: Global Continence Care Market Value (US$ Mn), by Urine Drainage Bags & Accessories, 2017‒2031
Figure 11: Global Continence Care Market Value (US$ Mn), by Absorbents, 2017‒2031
Figure 12: Global Continence Care Market Value (US$ Mn), by Penile Clamps, 2017‒2031
Figure 13: Global Continence Care Market Value (US$ Mn), by Non-implantable Electrical Stimulation Devices, 2017‒2031
Figure 14: Global Continence Care Market Value (US$ Mn), by Others, 2017‒2031
Figure 15: Global Continence Care Market Value Share Analysis, by Indication, 2020 and 2031
Figure 16: Global Continence Care Market Attractiveness Analysis, by Indication, 2021–2031
Figure 17: Global Continence Care Market Revenue (US$ Mn), by Urge Urinary Incontinence (UUI), 2017–2031
Figure 18: Global Continence Care Market Revenue (US$ Mn), by Stress Urinary Incontinence (SUI), 2017–2031
Figure 19: Global Continence Care Market Revenue (US$ Mn), by Mixed Urinary Incontinence (MUI), 2017–2031
Figure 20: Global Continence Care Market Revenue (US$ Mn), by Others, 2017–2031
Figure 21: Global Continence Care Market Value Share Analysis, by End-user, 2020 and 2031
Figure 22: Global Continence Care Market Attractiveness Analysis, by End-user, 2021–2031
Figure 23: Global Continence Care Market Revenue (US$ Mn), by Acute Care Facilities, 2017–2031
Figure 24: Global Continence Care Market Revenue (US$ Mn), by Long-term Care Facilities, 2017–2031
Figure 25: Global Continence Care Market Revenue (US$ Mn), by Home Care, 2017–2031
Figure 26: Global Continence Care Market Revenue (US$ Mn), by Others, 2017–2031
Figure 27: Global Continence Care Market Value Share Analysis, by Region, 2020 and 2031
Figure 28: Global Continence Care Market Attractiveness Analysis, by Region, 2021–2031
Figure 29: North America Continence Care Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: North America Continence Care Market Value Share Analysis, by Country, 2020 and 2031
Figure 31: North America Continence Care Market Attractiveness Analysis, by Country, 2021–2031
Figure 32: North America Continence Care Market Value Share Analysis, by Product Type , 2020 and 2031
Figure 33: North America Continence Care Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 34: North America Continence Care Market Value Share Analysis, by Indication, 2020 and 2031
Figure 35: North America Continence Care Market Attractiveness Analysis, by Indication, 2021–2031
Figure 36: North America Continence Care Market Value Share Analysis, by End-user, 2020 and 2031
Figure 37: North America Continence Care Market Attractiveness Analysis, by End-user, 2021–2031
Figure 38: Europe Continence Care Market Value (US$ Mn) Forecast, 2017–2031
Figure 39: Europe Continence Care Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 40: Europe Continence Care Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 41: Europe Continence Care Market Value Share Analysis, by Product Type , 2020 and 2031
Figure 42: Europe Continence Care Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 43: Europe Continence Care Market Value Share Analysis, by Indication, 2020 and 2031
Figure 44: Europe Continence Care Market Attractiveness Analysis, by Indication, 2021–2031
Figure 45: Europe Continence Care Market Value Share Analysis, by End-user, 2020 and 2031
Figure 46: Europe Continence Care Market Attractiveness Analysis, by End-user, 2021–2031
Figure 47: Asia Pacific Continence Care Market Value (US$ Mn) Forecast, 2017–2031
Figure 48: Asia Pacific Continence Care Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 49: Asia Pacific Continence Care Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 50: Asia Pacific Continence Care Market Value Share Analysis, by Product Type , 2020 and 2031
Figure 51: Asia Pacific Continence Care Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 52: Asia Pacific Continence Care Market Value Share Analysis, by Indication, 2020 and 2031
Figure 53: Asia Pacific Continence Care Market Attractiveness Analysis, by Indication, 2021–2031
Figure 54: Asia Pacific Continence Care Market Value Share Analysis, by End-user, 2020 and 2031
Figure 55: Asia Pacific Continence Care Market Attractiveness Analysis, by End-user, 2021–2031
Figure 56: Latin America Continence Care Market Value (US$ Mn) Forecast, 2017–2031
Figure 57: Latin America Continence Care Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 58: Latin America Continence Care Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 59: Latin America Continence Care Market Value Share Analysis, by Product Type , 2020 and 2031
Figure 60: Latin America Continence Care Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 61: Latin America Continence Care Market Value Share Analysis, by Indication, 2020 and 2031
Figure 62: Latin America Continence Care Market Attractiveness Analysis, by Indication, 2021–2031
Figure 63: Latin America Continence Care Market Value Share Analysis, by End-user, 2020 and 2031
Figure 64: Latin America Continence Care Market Attractiveness Analysis, by End-user, 2021–2031
Figure 65: Middle East & Africa Continence Care Market Value (US$ Mn) Forecast, 2017–2031
Figure 66: Middle East & Africa Continence Care Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 67: Middle East & Africa Continence Care Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 68: Middle East & Africa Continence Care Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 69: Middle East & Africa Continence Care Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 70: Middle East & Africa Continence Care Market Value Share Analysis, by Indication, 2020 and 2031
Figure 71: Middle East & Africa Continence Care Market Attractiveness Analysis, by Indication, 2021–2031
Figure 72: Middle East & Africa Continence Care Market Value Share Analysis, by End-user, 2020 and 2031
Figure 73: Middle East & Africa Continence Care Market Attractiveness Analysis, by End-user, 2021–2031
Figure 74: North America - Company Share Analysis, 2020
Figure 75: Europe - Company Share Analysis, 2020
Figure 76: Asia Pacific - Company Share Analysis, 2020
Figure 77: Latin America - Company Share Analysis, 2020
Figure 78: Middle East & Africa - Company Share Analysis, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Continence Care Market
